CLL was one of the few diseases that showed the general expression of SIRTs in patient samples, with SIRT1 being the most studied target, both in pathophysiological factors and in therapeutic approaches [59]. Here, SIRT1 is linked to B-cell chronic lymphocytic leukemia.